Erenumab: all 52 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)Not yet recruitingNCT07655440Phase 4
• Screening Trial for Pain Relief in Schwannomatosis (STARFISH)RecruitingNCT05684692Phase 2
• Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBIRecruitingNCT05049057Phase 2
• Registry for Migraine - Structural and Functional MRI Before and After Erenumab TreatmentRecruitingNCT04674020Phase 4
• Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With ErenumabRecruitingNCT04592952Phase 4
• Real World Effectiveness of Eptinezumab in Participants With MigraineTerminatedNCT05284019Phase 4Results posted
• Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE)TerminatedNCT05162027Phase 2Results posted
• Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.TerminatedNCT05142228Phase 2Results posted
• Safety and Efficacy of Erenumab-aooe in Patients With Temporomandibular DisorderCompletedNCT04884763Phase 2Results posted
• A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With MigraineCompletedNCT04825678Phase 4Results posted
• Efficacy of Erenumab on Functional Impact of MigraineCompletedNCT04465357Phase 4Results posted
• Erenumab For Treatment of Hemicrania ContinuaTerminatedNCT04303845Phase 2Results posted
• Biomarker and Genetic Predictors of Erenumab Treatment ResponseCompletedNCT04265755Phase 4Results posted
• Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic MigraineCompletedNCT04252742Phase 4Results posted
• Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With MigraineCompletedNCT04179474Phase 1Results posted
• Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTHCompletedNCT04098250Phase 2Results posted
• Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label StudyCompletedNCT04084314Phase 4Results posted
• A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse HeadacheCompletedNCT03971071Phase 4Results posted
• Study of Sustained Benefit of AMG334 in Adult Episodic Migraine PatientsCompletedNCT03927144Phase 4Results posted
• Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic MigraineTerminatedNCT03912337Phase 4Results posted
• Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine PatientsCompletedNCT03867201Phase 3Results posted
• Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic MigraineCompletedNCT03828539Phase 4Results posted
• A Controlled Trial of Erenumab in Migraine PreventionCompletedNCT03812224Phase 3Results posted
• Imaging the Migraine Brain Pre- and Post-ErenumabCompletedNCT03773562Phase 4Results posted
• AMG 334 20160172 Pediatric Migraine PK Study.CompletedNCT03499119Phase 1Results posted
• Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine PatientsCompletedNCT03333109Phase 3Results posted
• A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other TherapiesCompletedNCT03096834Phase 3Results posted
• Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy FemalesCompletedNCT02792517Phase 1Results posted
• Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous SumatriptanCompletedNCT02741310Phase 1Results posted
• A Safety and Efficacy Study to Evaluate AMG 334 in Migraine PreventionCompletedNCT02630459Phase 2Results posted
• Treadmill Cardiovascular Safety Study of Erenumab (AMG 334)CompletedNCT02575833Phase 2Results posted
• To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine PatientsCompletedNCT02542605Phase 1Results posted
• Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine PreventionCompletedNCT02483585Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine PreventionCompletedNCT02456740Phase 3Results posted
• A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.CompletedNCT02174861Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine PreventionCompletedNCT02066415Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine PreventionCompletedNCT01952574Phase 2Results posted
• Study of Erenumab (AMG 334) in Women With Hot FlashesCompletedNCT01890109Phase 1Results posted
• Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine PatientsCompletedNCT01723514Phase 1Results posted
• Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine PatientsCompletedNCT01688739Phase 1Results posted
• Investigational Use of Erenumab for the Treatment of Fibromyalgia PainWithdrawnNCT06411067Phase 3
• Efficacy of Erenumab in Chronic Cluster HeadacheCompletedNCT04970355Phase 2
• Study of Intravenous Erenumab in Patients With Status MigrainosusWithdrawnNCT04920331Phase 1
• Registry for Migraine - Clinical CoreStatus unknownNCT04603976Phase 4
• The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine PatientsStatus unknownNCT04452929Not applicable
• Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in RosaceaStatus unknownNCT04419259Phase 2
• Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With ErenumabWithdrawnNCT04114630Phase 3
• Efficacy and Tolerability of Erenumab in Patients With Trigeminal NeuralgiaStatus unknownNCT04054024Phase 2
• A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine PatientsCompletedNCT03977649Phase 4
• Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic HeadacheCompletedNCT03974360Phase 2
• Efficacy and Safety of Erenumab in Pediatric Participants With Episodic MigraineActive, not recruitingNCT03836040Phase 3
• Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic MigraineCompletedNCT03832998Phase 3

← Erenumab overview